The cardiovascular risk of patients with type 2 diabetes requires efficient therapy of all risk factors. A variety of new studies and guidelines have been published over the last year which will be presented and discussed in this article. These include lipid, diabetes and anti-thrombotic therapy in addition to revascularization and heart failure treatment.